Westchester Capital Management (New York)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Westchester Capital Management (New York)’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-681,856	Closed	-$12.3M	–	224
2020 Q2	$12.3M	Buy	+681,856	New	+$9.48M	0.54%	24

Westchester Capital Management (New York)'s PTLA Position: Q3 2020 in Review

Westchester Capital Management (New York) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 681,856 shares — an estimated $12.3M sold.

Westchester Capital Management (New York) first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $12.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Westchester Capital Management (New York) reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Westchester Capital Management (New York) sold 681,856 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $12.3M.
Westchester Capital Management (New York) first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
Westchester Capital Management (New York)'s Portola Pharmaceuticals, Inc. position peaked at $12.3M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2020, filed 16 Nov 2020.